TELA Bio Says FDA Cleared Liora Resorbable Surgical Mesh For Soft Tissue Reinforcement
Share
Why It Matters
TELA Bio got permission from the FDA to sell a new surgical mesh product. This shows the company can bring new things to doctors, which is good for growth.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.